LINC02122: A Potential Drug Target and Biomarker (G105379036)

Target Name: LINC02122

NCBI ID: G105379036

LINC02122

Other Name(s): LINC02122 variant X2 | Long intergenic non-protein coding RNA 2122, transcript variant X2 | long intergenic non-protein coding RNA 2122

LINC02122: A Potential Drug Target and Biomarker

LINC02122 is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. Its full name is long non-coding RNA gene X2, also known as U131617.2. LINC02122 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The LINC02122 protein is a non-coding RNA gene that contains 212 coding exons. It is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. LINC02122 has been shown to play a role in various biological processes, including cell adhesion, migration, and transcriptional regulation.

One of the most promising aspects of LINC02122 is its potential as a drug target. LINC02122 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its expression has been associated with the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

LINC02122 has also been shown to be a potential biomarker for various diseases. Its expression has been associated with the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that LINC02122 may be a useful biomarker for these diseases.

In addition to its potential as a drug target and biomarker, LINC02122 also has potential as a therapeutic agent. Its expression has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that LINC02122 may be a useful therapeutic agent for these diseases.

Overall, LINC02122 is a protein that has the potential to be a drug target and biomarker for various diseases. Further research is needed to fully understand its role in these diseases and to develop effective therapies based on its expression.

Protein Name: Long Intergenic Non-protein Coding RNA 2122

The "LINC02122 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02122 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets